Pharmafile Logo
Pharmafocus logo
Advanced Search

MSD

Showing 15 posts of 247 posts found.

Merck/MSD

MSD chooses partner to develop ‘game-changing’ cancer therapies

January 6, 2016
Research and Development CPABs, Cancer, Cell-Penetrating Alphabodies, Complix, MSD, autoimmune diseases

MSD has entered a research collaboration with biopharma company Complix, using the company’s proprietary technology to develop new treatments for …

News
Ebola virus

WHO to review MSD’s Ebola vaccine for emergency use

December 24, 2015
Manufacturing and Production, Research and Development Ebola vaccine, Ebola virus, MSD, WHO, Zebov

The World Health Organisation (WHO) has accepted MSD’s application for the company’s investigational Ebola vaccine, V920 (Zebov), to be reviewed …

News
Keytruda image

MSD’s Keytruda impresses in lung cancer chemotherapy trial

December 21, 2015
Manufacturing and Production, Research and Development MSD, PD-L1, docetaxel, keytruda, lung cancer, non small cell lung cancer, non-small cell lung cancer, pd-1, pembrolizumab

MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …

News
jessica_fine

MSD UK appoints Jessica Fine as executive director of external affairs

December 16, 2015
Medical Communications Jessica Fine, MSD

MSD has appointed former Lexington Health boss Jessica Fine to lead its external affairs team in the UK from April …

Appointment
Keytruda image

MSD’s Keytruda shows promise in multiple myeloma

December 7, 2015
Manufacturing and Production MSD, Revlimid, dexamethasone, keytruda, multiple myeloma, pembrolizumab

MSD has announced that it has initiated two Phase III studies based in part on the strength of early data, …

News
Merck image

Sales up at MSD while Keytruda hits survival target in late-stage trial

October 28, 2015
Research and Development, Sales and Marketing MSD, Merck, financial results, keytruda, pembrolizumab

Worldwide sales at MSD were $10.1 billion in the third quarter of 2015, a 4% increase after accounting for the …

News
Ezetrol

NICE issues draft guidance for MSD’s Ezetrol

October 21, 2015
Sales and Marketing MSD, NICE, cardiovascular disease, ezetimibie, ezetrol, high cholesterol

NICE has published draft guidance recommending MSD’s Ezetrol as an option for some adults with high cholesterol.  The guidance updates …

News
keytruda3-web

MSD’s Keytruda receives green light from NICE for NHS use

October 12, 2015
Sales and Marketing MSD, Merck, NICE, keytruda, melanoma, pembrolizumab, skin cancer

The UK healthcare watchdog NICE has recommended Keytruda as a treatment for advanced skin cancer – its second endorsement of …

News
velocity_health

Merck and Wayra to tackle NHS funding gap with startup rewards programme

September 25, 2015
Research and Development MSD, Merck

Merck Sharpe and Dohme (MSD) and Wayra Open Future, Telefonica’s digital start up accelerator, are investing in digital innovation in …

News

David Khougazian announced as president of Sanofi Pasteur MSD

July 29, 2015
Business Services, Research and Development, Sales and Marketing MSD, Merck, Sanofi Pasteur

Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …

Appointment
Merck logo

Merck launches new antibiotic in the UK

June 5, 2015
Research and Development, Sales and Marketing AMR, Antibiotics, MSD, Merck, Sivextro, antimicrobial resistance, cubist, tedizolid phosphate

Merck has launched the first new drug in a class of antibiotics in the UK in almost 15 years, becoming …

News
Hospira image

Hospira launches biosimilar monoclonal antibody

February 16, 2015
Research and Development, Sales and Marketing MSD, Merck, Remicade, biosimilar. hospira, inflectra, infliximab

Hospira has won the race to become the first company to launch a biosimilar version of an anti-TNF biologic, after …

News
Bruno image

Novartis hires Merck president to lead oncology

June 3, 2014
Medical Communications, Research and Development, Sales and Marketing Bruno Strigini, MSD, Merck, Novartis, oncology

Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology.  The role was …

News
MSD image

Endocyte lung cancer drug shows promise

March 24, 2014
Research and Development, Sales and Marketing Endocyte, MSD, NSCLC, lung cancer, vintafolide

Endocyte and partner MSD have released positive mid-stage trial results for their investigational lung cancer drug vintafolide. The treatment met …

News
mike_nally_new_msd_uk_md

Mike Nally replaces Deepak Khanna as MSD head

December 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, mike nally

Merck Sharp & Dohme has confirmed that Mike Nally will succeed Deepak Khanna as managing director for MSD in the …

Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026